Citations (92)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yinhan Guo, Tingting Guo, Yujing Di, Wenyu Xu, Zhitian Hu, Yanfeng Xiao, Heze Yu & Jie Hou. (2023) Pharmacokinetics, pharmacodynamics, safety and immunogenicity of recombinant, fully human anti-RANKL monoclonal antibody (MW031) versus denosumab in Chinese healthy subjects: a single-center, randomized, double-blind, single-dose, parallel-controlled trial. Expert Opinion on Biological Therapy 23:8, pages 705-715.
Read now
Read now
Fernanda R. Rocho, Vinícius Bonatto, Rafael F. Lameiro, Jerônimo Lameira, Andrei Leitão & Carlos A. Montanari. (2022) A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021). Expert Opinion on Therapeutic Patents 32:5, pages 561-573.
Read now
Read now
Maria V. Deligiorgi & Dimitrios T. Trafalis. (2021) The safety profile of denosumab in oncology beyond the safety of denosumab as an anti-osteoporotic agent: still more to learn. Expert Opinion on Drug Safety 20:2, pages 191-213.
Read now
Read now
Andreas Fontalis, Eustathios Kenanidis, Rafail Angelos Kotronias, Afroditi Papachristou, Panagiotis Anagnostis, Michael Potoupnis & Eleftherios Tsiridis. (2019) Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss. Expert Opinion on Pharmacotherapy 20:9, pages 1123-1134.
Read now
Read now
Luigi Gennari, Stefano Rotatori, Simone Bianciardi, Ranuccio Nuti & Daniela Merlotti. (2016) Treatment needs and current options for postmenopausal osteoporosis. Expert Opinion on Pharmacotherapy 17:8, pages 1141-1152.
Read now
Read now
Articles from other publishers (87)
Lalit Kumar, Mohit Kumar Arora & Sunil Marwah. (2023) Biologic Antiresorptive: Denosumab. Indian Journal of Orthopaedics.
Crossref
Crossref
Sara Whitefield, Mor Bar Ilan, Towy Sorel Lazarovici, Silvina Friedlander-Barenboim, Riad Kassem & Yarom Noam. (2023) Medication-related osteonecrosis of the jaw: A cross-sectional study on the prevalence of cutaneous manifestations and the primary care physician's role in its early diagnosis. The American Journal of Medicine.
Crossref
Crossref
Shiva Shankar Jha. (2023) Biologics: Teriparatide and Newer Anabolics. Indian Journal of Orthopaedics.
Crossref
Crossref
Juan Carlos Sánchez-García, Daniel López Hernández, Beatriz Piqueras-Sola, Jonathan Cortés-Martín, Andrés Reinoso-Cobo, María José Menor-Rodríguez & Raquel Rodríguez-Blanque. (2023) Physical Exercise and Dietary Supplementation in Middle-Aged and Older Women: A Systematic Review. Journal of Clinical Medicine 12:23, pages 7271.
Crossref
Crossref
Ko Chiba, Naoki Iwamoto, Kounosuke Watanabe, Kazuteru Shiraishi, Kengo Saito, Naoki Okubo, Atsushi Kawakami & Makoto Osaki. (2023) Denosumab improves bone mineral density and microarchitecture in rheumatoid arthritis: randomized controlled trial by HR-pQCT. Journal of Bone and Mineral Metabolism 41:6, pages 797-806.
Crossref
Crossref
Djoko Santoso, Mochammad Thaha, Maulana A. Empitu, Ika Nindya Kadariswantiningsih, Satriyo Dwi Suryantoro, Mutiara Rizki Haryati, Decsa Medika Hertanto, Dana Pramudya, Siprianus Ugroseno Yudho Bintoro, Nasronudin Nasronudin, Mochamad Yusuf Alsagaff, Hendri Susilo, Citrawati Dyah Kencono Wungu, Nicolaas C. Budhiparama & Pancras C. W. Hogendoorn. (2023) Brown Tumour in Chronic Kidney Disease: Revisiting an Old Disease with a New Perspective. Cancers 15:16, pages 4107.
Crossref
Crossref
Takuya Ono, Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Ryuto Tsuchiya, Taro Akiyama, Naoki Kojima, Yu Toda, Chiaki Sato, Suguru Fukushima, Akihiko Yoshida, Akira Kawai & Tadashi Kondo. (2023) Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone. Human Cell 36:5, pages 1804-1812.
Crossref
Crossref
Sriharsha Dadana, Sai Gundepalli & Anusha Kondapalli. (2023) Severe Refractory Hypocalcemia Caused by Denosumab. Cureus.
Crossref
Crossref
Theo Gulen. (2023) Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis. Immunology and Allergy Clinics of North America.
Crossref
Crossref
Halise Hande Gezer & Andrew Ostor. (2023) What is new in pharmacological treatment for osteoarthritis?. Best Practice & Research Clinical Rheumatology, pages 101841.
Crossref
Crossref
Mikkel Bo Brent. (2023) Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies. Pharmacology & Therapeutics 244, pages 108383.
Crossref
Crossref
Xiao Li, Jingru Han, Xiaotong Shi, Zhiguo Bi & Jianguo Liu. (2023) Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials. Archives of Osteoporosis 18:1.
Crossref
Crossref
Jingyi Wen, Donglin Cai, Wendong Gao, Ruiying He, Yulin Li, Yinghong Zhou, Travis Klein, Lan Xiao & Yin Xiao. (2023) Osteoimmunomodulatory Nanoparticles for Bone Regeneration. Nanomaterials 13:4, pages 692.
Crossref
Crossref
Gemma Marcucci, Vladana Domazetovic, Chiara Nediani, Jessica Ruzzolini, Claudio Favre & Maria Luisa Brandi. (2023) Oxidative Stress and Natural Antioxidants in Osteoporosis: Novel Preventive and Therapeutic Approaches. Antioxidants 12:2, pages 373.
Crossref
Crossref
Anjali Pant, Joga Singh, Ravi Pratap Barnwal, Gurpal Singh & Bhupinder Singh. (2023) Theranostic Approach for the Management of Osteoporosis. Critical Reviews™ in Therapeutic Drug Carrier Systems 40:3, pages 95-121.
Crossref
Crossref
Annop Kittithaworn, David Toro-Tobon & Jad G Sfeir. (2023) Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragility. Women's Health 19, pages 174550572311700.
Crossref
Crossref
Iddrisu Ibrahim, Soumyakrishnan Syamala, Joseph Atia Ayariga, Junhuan Xu, Boakai K. Robertson, Sreepriya Meenakshisundaram & Olufemi S. Ajayi. (2022) Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids. Metabolites 12:12, pages 1247.
Crossref
Crossref
Naoki Iwamoto, Ko Chiba, Shuntaro Sato, Kazuteru Shiraishi, Kounosuke Watanabe, Nozomi Oki, Akitomo Okada, Tomohiro Koga, Shin-ya Kawashiri, Mami Tamai, Naoki Hosogaya, Masako Furuyama, Makiko Kobayashi, Kengo Saito, Naoki Okubo, Masataka Uetani, Makoto Osaki & Atsushi Kawakami. (2022) Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone: an open-label, randomized, parallel-group study. Arthritis Research & Therapy 24:1.
Crossref
Crossref
Ceyda Dincer Yazan, Onur Bugdayci, Can Ilgin & Dilek Gogas Yavuz. (2022) Effect of denosumab treatment on bone mineral density and bone turnover markers in osteoporotic patients: real-life experience 2-year follow-up. Archives of Osteoporosis 17:1.
Crossref
Crossref
Michael Morkos, Paul Mahrous, Alessandra Casagrande, Muriel Tania Go, Hasan Husni, Mirette Hanna, Mishita Goel, Sara Bedrose, Dingfeng Li & Sanford Baim. (2022) Patterns of Osteoporosis Medications Selection After Drug Holiday or Continued Therapy: A Real-World Experience. Endocrine Practice 28:10, pages 1078-1085.
Crossref
Crossref
M. S. LeBoff, S. L. Greenspan, K. L. Insogna, E. M. Lewiecki, K. G. Saag, A. J. Singer & E. S. Siris. (2022) The clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International 33:10, pages 2049-2102.
Crossref
Crossref
Lin-Yu Jin, Shi-Cheng Huo, Chen Guo, Hai-Ying Liu, Shuai Xu & Xin-Feng Li. (2022) GSK 650394 Inhibits Osteoclasts Differentiation and Prevents Bone Loss via Promoting the Activities of Antioxidant Enzymes In Vitro and In Vivo. Oxidative Medicine and Cellular Longevity 2022, pages 1-20.
Crossref
Crossref
Jun Hou, Hongjie Su, Xiaocong Kuang, Wencong Qin, Kaibing Liu, Kaixiang Pan, Bokai Zhang, Sijie Yang, Shenghui Yang, Xiao Peng, Xinyu Nie & Qikai Hua. (2022) Knowledge Domains and Emerging Trends of Osteoblasts-Osteoclasts in Bone Disease From 2002 to 2021: A Bibliometrics Analysis and Visualization Study. Frontiers in Endocrinology 13.
Crossref
Crossref
Dionna Jacobson, Benoit Cadieux, Celestia S. Higano, David H. Henry, Basia A. Bachmann, Marko Rehn, Alison T. Stopeck & Hossam Saad. (2022) Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach. Journal of Bone Oncology 34, pages 100423.
Crossref
Crossref
Megumi Ikeda, Akiko Karakawa, Hideomi Takizawa, Yuki Azetsu, Nobuhiro Sakai, Masahiro Chatani, Noriyuki Suzuki & Masamichi Takami. (2022) Effects of Anti–Receptor Activator of Nuclear Factor Kappa B Ligand Antibody and Zoledronic Acid on Periapical Lesion Development in Mice. Journal of Endodontics 48:5, pages 632-640.
Crossref
Crossref
Sakae Tanaka, Makiko Kobayashi, Kengo Saito & Atsushi Takita. (2022) Impact of denosumab discontinuation on changes in bone mineral density and bone erosion in rheumatoid arthritis patients. Modern Rheumatology 32:2, pages 284-291.
Crossref
Crossref
Raju Vaishya, Abhishek Vaish, Nishant Pawar & Pankaj Baweja. (2022) Aggressive giant cell tumour (GCT) of the distal humerus in a young pregnant woman. BMJ Case Reports 15:2, pages e246001.
Crossref
Crossref
Tanja Jankovic, Aleksandra Savic, Jelena Zvekic-Svorcan, Marina Maksimovic-Simovic & Ksenija Boskovic. (2022) Biological therapy for osteoporosis - solving clinical problems - a case report. Medicinski pregled Medical review 75:Suppl. 2, pages 22-27.
Crossref
Crossref
Win Min Oo & David J. Hunter. (2022) Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs). Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2210902.
Crossref
Crossref
Filippo Migliorini, Nicola Maffulli, Giorgia Colarossi, Jörg Eschweiler, Markus Tingart & Marcel Betsch. (2021) Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. Journal of Orthopaedic Surgery and Research 16:1.
Crossref
Crossref
Tetsuo Hasegawa, Junichi Kikuta & Masaru Ishii. (2021)
Imaging of bone and joints
in vivo
: pathological osteoclastogenesis in arthritis
. International Immunology 33:12, pages 679-686.
Crossref
Crossref
Wanuttha Boonyayothin, Sirorut Sinnung, Balamurugan Shanmugaraj, Yoshito Abe, Richard Strasser, Prasit Pavasant & Waranyoo Phoolcharoen. (2021) Expression and Functional Evaluation of Recombinant Anti-receptor Activator of Nuclear Factor Kappa-B Ligand Monoclonal Antibody Produced in Nicotiana benthamiana. Frontiers in Plant Science 12.
Crossref
Crossref
Guoju Hong, Zhenqiu Chen, Xiaorui Han, Lin Zhou, Fengxiang Pang, Rishana Wu, Yingshan Shen, Xiaoming He, Zhinan Hong, Ziqi Li, Wei He & Qiushi Wei. (2021) A novel RANKL‐targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species. Clinical and Translational Medicine 11:5.
Crossref
Crossref
Young Jong Ko, Hong Moon Sohn, Yuria Jang, Mineon Park, Bora Kim, Beomchang Kim, Jae‐Il Park, Hoon Hyun, Byeongseok Jeong, Chansik Hong & Wonbong Lim. (2021) A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor. Clinical and Translational Medicine 11:3.
Crossref
Crossref
Francesca Salamanna, Alessandro Gambardella, Deyanira Contartese, Andrea Visani & Milena Fini. (2021) Nano-Based Biomaterials as Drug Delivery Systems Against Osteoporosis: A Systematic Review of Preclinical and Clinical Evidence. Nanomaterials 11:2, pages 530.
Crossref
Crossref
Richard Pope & Joan Doback. (2021) Osteoporosis Diagnosis and Management. Physician Assistant Clinics 6:1, pages 111-133.
Crossref
Crossref
Deborah T. Gold. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis
1695
1707
.
Sushil Kiran Kunder & Avinash Arivazhahan. 2021. Introduction to Basics of Pharmacology and Toxicology. Introduction to Basics of Pharmacology and Toxicology
751
760
.
Donald M. Caraccio & Morgan S. Jones. 2021. Clinical Foundations of Musculoskeletal Medicine. Clinical Foundations of Musculoskeletal Medicine
77
93
.
Amerigo Giudice, Alessandro Antonelli, Emanuela Chiarella, Francesco Baudi, Tullio Barni & Anna Di Vito. (2020) The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes. Pharmaceuticals 13:12, pages 423.
Crossref
Crossref
Elisa Fernández Fernández, Diego Benavent Núñez, Gema Bonilla Hernán, Irene Monjo Henry, Sara García Carazo, Miguel Bernad Pineda, Alejandro Balsa Criado & Pilar Aguado Acín. (2020) Multiple vertebral fractures following discontinuation of denosumab treatment: ten clinical cases report. Reumatología Clínica (English Edition) 16:6, pages 480-484.
Crossref
Crossref
Elisa Fernández Fernández, Diego Benavent Núñez, Gema Bonilla Hernán, Irene Monjo Henry, Sara García Carazo, Miguel Bernad Pineda, Alejandro Balsa Criado & Pilar Aguado Acín. (2020) Fracturas vertebrales múltiples tras la suspensión de tratamiento con denosumab: serie de diez casos. Reumatología Clínica 16:6, pages 480-484.
Crossref
Crossref
Faez Saleh Al-Hamed, Ola M. Maria, Jeff Phan, Ahmed Al Subaie, Qiman Gao, Alaa Mansour, Lina Abu Nada, Imane Boukhatem, Osama A. Elkashty, Simon D. Tran, Marie Lordkipanidzé, Zahi Badran & Faleh Tamimi. (2020) Postoperative Administration of the Acetylcholinesterase Inhibitor, Donepezil, Interferes with Bone Healing and Implant Osseointegration in a Rat Model. Biomolecules 10:9, pages 1318.
Crossref
Crossref
Wenjuan Zhang, Kai Dang, Ying Huai & Airong Qian. (2020) Osteoimmunology: The Regulatory Roles of T Lymphocytes in Osteoporosis. Frontiers in Endocrinology 11.
Crossref
Crossref
Janak L. Pathak, Nathalie Bravenboer & Jenneke Klein-Nulend. (2020) The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases. Frontiers in Endocrinology 11.
Crossref
Crossref
Giuseppina Campisi, Rodolfo Mauceri, Francesco BERTOLDO, Vittorio Fusco & Alberto Bedogni. (2020) Simplifying the dental/periodontal management of patients with metabolic bone fragility receiving treatment with denosumab. Qeios.
Crossref
Crossref
Iratxe Macías, Natividad Alcorta-Sevillano, Clara I. Rodríguez & Arantza Infante. (2020) Osteoporosis and the Potential of Cell-Based Therapeutic Strategies. International Journal of Molecular Sciences 21:5, pages 1653.
Crossref
Crossref
Tetsuo HASEGAWA & Masaru ISHII. (2020) Visualizing bone tissue in homeostatic and pathological conditions. Proceedings of the Japan Academy, Series B 96:2, pages 43-49.
Crossref
Crossref
Miguel Gisbert-Garzarán, Miguel Manzano & María Vallet-Regí. (2020) Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis. Pharmaceutics 12:1, pages 83.
Crossref
Crossref
J. Peter R. Pelletier & Faisal Mukhtar. 2020. Immunologic Concepts in Transfusion Medicine. Immunologic Concepts in Transfusion Medicine
251
348
.
Mariela AgotegarayMariela Agotegaray. 2020. Silica-Based Nanotechnology for Bone Disease Treatment. Silica-Based Nanotechnology for Bone Disease Treatment
25
38
.
Yu-chen Guo & Quan Yuan. 2020. Dental Implant Treatment in Medically Compromised Patients. Dental Implant Treatment in Medically Compromised Patients
73
101
.
Tomohisa Kunii, Toshie Iijima, Teruo Jojima, Masanori Shimizu, Masato Kase, Shintaro Sakurai, Takahiko Kogai, Isao Usui & Yoshimasa Aso. (2019) Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report. Journal of Medical Case Reports 13:1.
Crossref
Crossref
Shimon Amselem. (2019) Remote Controlled Autonomous Microgravity Lab Platforms for Drug Research in Space. Pharmaceutical Research 36:12.
Crossref
Crossref
Konica Porwal, Subhashis Pal, Deepshikha Tewari, Shyamsundar Pal China, Priya Singh, Mahesh Chandra Tewari, Gurudayal Prajapati, Pragati Singh, Srikanth Cheruvu, Yasir A Khan, Sabyasachi Sanyal, Jiaur R Gayen, Ravishankar Ampapathi, Asit R Mridha & Naibedya Chattopadhyay. (2019) Increased Bone Marrow-Specific Adipogenesis by Clofazimine Causes Impaired Fracture Healing, Osteopenia, and Osteonecrosis Without Extraskeletal Effects in Rats. Toxicological Sciences 172:1, pages 167-180.
Crossref
Crossref
Caroline Davidge-Pitts & Bart L. Clarke. (2019) Transgender bone health. Maturitas 127, pages 35-42.
Crossref
Crossref
Sali Sujitha & Mahaboobkhan Rasool. (2019) Berberine coated mannosylated liposomes curtail RANKL stimulated osteoclastogenesis through the modulation of GSK3β pathway via upregulating miR-23a. International Immunopharmacology 74, pages 105703.
Crossref
Crossref
Katerina Trajanoska & Fernando Rivadeneira. (2019) The genetic architecture of osteoporosis and fracture risk. Bone 126, pages 2-10.
Crossref
Crossref
Yong Xie, Licheng Zhang, Qi Xiong, Yanpan Gao, Wei Ge & Peifu Tang. (2019) Bench-to-bedside strategies for osteoporotic fracture: From osteoimmunology to mechanosensation. Bone Research 7:1.
Crossref
Crossref
Sabrina Ehnert, Romina H. Aspera-Werz, Marc Ruoß, Steven Dooley, Jan G. Hengstler, Silvio Nadalin, Borna Relja, Andreas Badke & Andreas K. Nussler. (2019) Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development. International Journal of Molecular Sciences 20:10, pages 2555.
Crossref
Crossref
Jong Min Baek, Sung Chul Kwak, Kwon-Ha Yoon, Ju-Young Kim & Myeung Su Lee. (2019) Role of ANTXR1 in the regulation of RANKL-induced osteoclast differentiation and function. Biochemical and Biophysical Research Communications 510:2, pages 296-302.
Crossref
Crossref
Ourania Nicolatou-Galitis, Morten Schiødt, Rui Amaral Mendes, Carla Ripamonti, Sally Hope, Lawrence Drudge-Coates, Daniela Niepel & Tim Van den Wyngaert. (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 127:2, pages 117-135.
Crossref
Crossref
Đurđa CvjetkovićM.M., Sara Cvjetković-NedeljkovićM.M., Nikola MartićB.B., Ana SaboJ.J., Zdenko TomićS.S. & Boris MilijaševićŽ.Ž.. (2019) Analysis of utilization of bisphosphonates, strontium ranelate and denosumabe in Serbia, Finland, Norway and Denmark in the period 2013-2016. Hospital Pharmacology - International Multidisciplinary Journal 6:3, pages 857-867.
Crossref
Crossref
AartiAbhishek Shah, Karthik Gourishetti & Yogendra Nayak. (2019) Osteogenic activity of resveratrol in human fetal osteoblast cells. Pharmacognosy Magazine 15:64, pages 250.
Crossref
Crossref
Sharzad Alagheband, Catherine Cranford & Patricia Stewart. 2019. Allergy and Asthma. Allergy and Asthma
1
33
.
Sharzad Alagheband, Catherine Cranford & Patricia Stewart. 2019. Allergy and Asthma. Allergy and Asthma
645
677
.
Vladimira Schwartzova, Marcel Riznic, Branislav Borza & Peter Kizek. 2018. Newest Updates in Rheumatology. Newest Updates in Rheumatology.
Aline Granja Costa, E. Michael Lewiecki & John P. Bilezikian. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
553
558
.
Antoine Boulanger Piette, Dounia Hamoudi, Laetitia Marcadet, Françoise Morin, Anteneh Argaw, Leanne Ward & Jérôme Frenette. (2018) Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy. Current Osteoporosis Reports 16:5, pages 541-553.
Crossref
Crossref
Mehdi Shadmand, Krista Jackson, Cecelia Bender, Stephen Donnelly, Henry Guan, Kirby Tobin, Sydni Yates, Julia Hum & Jonathan W. Lowery. (2018) Bringing Attention to Lesser-known Bone Remodeling Pathways. Clinical Reviews in Bone and Mineral Metabolism 16:3, pages 95-102.
Crossref
Crossref
Hari Madhuri Doss, Snigdha Samarpita, Ramamoorthi Ganesan & Mahaboobkhan Rasool. (2018) Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathway. Life Sciences 207, pages 284-295.
Crossref
Crossref
C. Thongprayoon, P. Acharya, C. Acharya, J. Chenbhanich, T. Bathini, B. Boonpheng, K. Sharma, K. Wijarnpreecha, P. Ungprasert, M.L. Gonzalez Suarez & W. Cheungpasitporn. (2018) Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies. Osteoporosis International 29:8, pages 1737-1745.
Crossref
Crossref
Teri Capriotti & Meghan Scanlon. (2018) Osteoporosis. Home Healthcare Now 36:4, pages 216-224.
Crossref
Crossref
Matthew C. Walsh, Noriko Takegahara, Hyunsoo Kim & Yongwon Choi. (2018) Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity. Nature Reviews Rheumatology 14:3, pages 146-156.
Crossref
Crossref
N. N. Yakovenchuk. (2018) INFLUENCE OF DENOSUMABLE ON MINERAL BONE TISSUE DENSITY IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS. Bulletin of Problems Biology and Medicine 1:2, pages 207.
Crossref
Crossref
R. Bakhchinian, F. Bouchoux & S. Kirkiacharian. (2017) Synthèse et affinité de fixation aux récepteurs d’hormones stéroïdes humains de 3-phénoxy-4-hydroxycoumarines et de 3-phénoxy-4-phénylcoumarines. Annales Pharmaceutiques Françaises 75:6, pages 455-462.
Crossref
Crossref
Theo Gülen & Cem Akin. (2017) Pharmacotherapy of mast cell disorders. Current Opinion in Allergy & Clinical Immunology 17:4, pages 295-303.
Crossref
Crossref
Su Young Kim, Hwoe Gyeong Ok, Christof Birkenmaier & Kyung Hoon Kim. (2017) Can denosumab be a substitute, competitor, or complement to bisphosphonates?. The Korean Journal of Pain 30:2, pages 86-92.
Crossref
Crossref
Michael Croft & Richard M. Siegel. (2017) Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases. Nature Reviews Rheumatology 13:4, pages 217-233.
Crossref
Crossref
Benjamin D. Elder, Wataru Ishida, C. Rory Goodwin, Ali Bydon, Ziya L. Gokaslan, Daniel M. Sciubba, Jean-Paul Wolinsky & Timothy F. Witham. (2017) Bone graft options for spinal fusion following resection of spinal column tumors: systematic review and meta-analysis. Neurosurgical Focus 42:1, pages E16.
Crossref
Crossref
Patricia Westmoreland, Mori J. Krantz & Philip S. Mehler. (2016) Medical Complications of Anorexia Nervosa and Bulimia. The American Journal of Medicine 129:1, pages 30-37.
Crossref
Crossref
F. Jakob, F. Genest, G. Baron, U. Stumpf, M. Rudert & L. Seefried. (2015) Regulation des Knochenstoffwechsels bei OsteoporoseRegulation of bone metabolism in osteoporosis. Der Unfallchirurg 118:11, pages 925-932.
Crossref
Crossref
Polyzois Makras, Sideris Delaroudis & Athanasios D. Anastasilakis. (2015) Novel therapies for osteoporosis. Metabolism 64:10, pages 1199-1214.
Crossref
Crossref
Nicole M. I?iguez-Ariza & Bart L. Clarke. (2015) Bone biology, signaling pathways, and therapeutic targets for osteoporosis. Maturitas 82:2, pages 245-255.
Crossref
Crossref
V. V. Zhukouskaya, C. Eller-Vainicher, A. P. Shepelkevich, Y. Dydyshko, E. Cairoli & I. Chiodini. (2015) Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice. Journal of Endocrinological Investigation 38:9, pages 941-950.
Crossref
Crossref
Paul A. Carpenter, Carrie L. Kitko, Sharon Elad, Mary E.D. Flowers, Juan C. Gea-Banacloche, Jörg P. Halter, Flora Hoodin, Laura Johnston, Anita Lawitschka, George B. McDonald, Anthony W. Opipari, Bipin N. Savani, Kirk R. Schultz, Sean R. Smith, Karen L. Syrjala, Nathaniel Treister, Georgia B. Vogelsang, Kirsten M. Williams, Steven Z. Pavletic, Paul J. Martin, Stephanie J. Lee & Daniel R. Couriel. (2015) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biology of Blood and Marrow Transplantation 21:7, pages 1167-1187.
Crossref
Crossref
Michel Arock, Cem Akin, Olivier Hermine & Peter Valent. (2015) Current treatment options in patients with mastocytosis: status in 2015 and future perspectives. European Journal of Haematology 94:6, pages 474-490.
Crossref
Crossref